Saturday 17 October 2026 Export SLS’s income statement to Excel — free account

SELLAS Life Sciences Group, Inc.

SELLAS Life Sciences Group, Inc.’s revenue for fiscal 2022 (year ended December 2022) was $1.0 million. In the quarter to June 2026, EPS grew 28.6% and free cash flow fell 3.52%, each against the same quarter a year earlier. Insiders bought in the last twelve months.

9.98 1.36 −11.99%

Follow SLS

Alert me

Market cap: $2.3B
P/E: 0.0×
Fwd P/E: −10.0×
Dividend yield: —
F-score: 2/9
Altman Z: −16.75
Beneish M: n/a
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

	Jun '26	Mar '26	Dec '25	Sep '25	Older periods
ROE Full definition →	(39.63%)	(43.58%)	(66.88%)	(84.33%)	+8 more TTM periods Free account
ROA Full definition →	(36.54%)	(39.50%)	(54.95%)	(66.47%)
ROIC Full definition →	0.00%	(9,146.22%)	0.00%	(1,391.37%)
Return on Tangible Assets Full definition →	(24.06%)	(28.13%)	(39.39%)	(60.15%)
Average Days of Receivables Full definition →	—	—	—	—
Free Cash Flow per Share Full definition →	(0.15)	(0.16)	(0.26)	(0.28)
Free Cash Flow Full definition →	(28.42)	(28.16)	(28.39)	(30.62)
Other line items
Cash ROIC Full definition →	(10.29%)	(13.12%)	(19.89%)	(34.00%)
Accounts Payable Turnover Full definition →	0.00	0.00	0.00	0.00
Average Days of Payables Full definition →	0.00	0.00	0.00	0.00
Tax Rate Full definition →	0.00	0.00	0.00	0.00
Research and Development Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Selling, General and Administrative Expense of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Share Based Compensation of Revenue Full definition →	0.00%	0.00%	0.00%	0.00%
Operating CF/Net income Full definition →	0.88	0.96	1.06	1.18
Revenue per Share Full definition →	0.00	0.00	0.00	0.00
Operating CF per Share Full definition →	(0.15)	(0.16)	(0.26)	(0.28)
Capex per Share Full definition →	0.00	0.00	0.00	0.00

Show all line items

Columns are period end dates

Stockrow Weekly